Steroid-Sparing Therapy for Tyrosine Kinase Inhibitor-Induced Pneumonitis

J Thorac Oncol. 2019 Apr;14(4):e75-e77. doi: 10.1016/j.jtho.2018.11.030.

Authors

Thomas Yang Sun¹, Arthur W Sung², Joel W Neal³

Affiliations

¹ Department of Medical Oncology, Stanford Cancer Institute, Stanford, California.
² Department of Medicine, Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California.
³ Department of Medical Oncology, Stanford Cancer Institute, Stanford, California. Electronic address: jwneal@stanford.edu.

PMID: 30922583
DOI: 10.1016/j.jtho.2018.11.030

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Humans
Male
Pneumonia / chemically induced*
Protein Kinase Inhibitors / adverse effects*

Substances

Protein Kinase Inhibitors